- Home
- MIRA vs NYC Comparison
MIRA vs NYC Comparison
Compare MIRA & NYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIRA
- NYC
- Stock Information
- Founded
- MIRA 2020
- NYC 2013
- Country
- MIRA United States
- NYC United States
- Employees
- MIRA 6
- NYC N/A
- Industry
- MIRA Biotechnology: Pharmaceutical Preparations
- NYC Real Estate
- Sector
- MIRA Health Care
- NYC Finance
- Exchange
- MIRA Nasdaq
- NYC Nasdaq
- Market Cap
- MIRA 17.4M
- NYC 23.8M
- IPO Year
- MIRA 2023
- NYC N/A
- Fundamental
- Price
- MIRA $1.09
- NYC $8.51
- Analyst Decision
- MIRA Strong Buy
- NYC
- Analyst Count
- MIRA 2
- NYC 0
- Target Price
- MIRA $14.00
- NYC N/A
- AVG Volume (30 Days)
- MIRA 493.9K
- NYC 3.3K
- Earning Date
- MIRA 11-12-2024
- NYC 11-12-2024
- Dividend Yield
- MIRA N/A
- NYC N/A
- EPS Growth
- MIRA N/A
- NYC N/A
- EPS
- MIRA N/A
- NYC N/A
- Revenue
- MIRA N/A
- NYC $62,060,000.00
- Revenue This Year
- MIRA N/A
- NYC N/A
- Revenue Next Year
- MIRA N/A
- NYC $3.18
- P/E Ratio
- MIRA N/A
- NYC N/A
- Revenue Growth
- MIRA N/A
- NYC N/A
- 52 Week Low
- MIRA $0.51
- NYC $5.46
- 52 Week High
- MIRA $5.01
- NYC $10.91
- Technical
- Relative Strength Index (RSI)
- MIRA 37.31
- NYC 47.19
- Support Level
- MIRA $1.04
- NYC $7.96
- Resistance Level
- MIRA $1.16
- NYC $9.15
- Average True Range (ATR)
- MIRA 0.10
- NYC 0.50
- MACD
- MIRA -0.02
- NYC 0.05
- Stochastic Oscillator
- MIRA 24.29
- NYC 49.21
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
About NYC American Strategic Investment Co.
American Strategic Investment Co is an externally managed company that currently owns a portfolio of commercial real estate located within the five boroughs of New York City, majorly Manhattan. The Company's real estate assets consist of office properties and certain real estate assets that accompany office properties, including retail spaces and amenities.